ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹269 Cr | ₹52 Cr | ₹107 Cr | ₹-86 Cr | ₹73 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ABBOTT INDIA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹-86 Cr |
| Mar2021 | ₹73 Cr |
How is Net Cash Inflow / Outflow of ABBOTT INDIA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹269 Cr | 416.32 | |
| Mar2024 | ₹52 Cr | -51.32 | |
| Mar2023 | ₹107 Cr | Positive | |
| Mar2022 | ₹-86 Cr | Negative | |
| Mar2021 | ₹73 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹57,504.8 Cr | 3.5% | 2.4% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 3.5% |
2.4% |
-25.9% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses